Imputation of a true endpoint from a surrogate: application to a cluster randomized controlled trial with partial information on the true endpoint
نویسندگان
چکیده
BACKGROUND The Anglia Menorrhagia Education Study (AMES) is a randomized controlled trial testing the effectiveness of an education package applied to general practices. Binary data are available from two sources; general practitioner reported referrals to hospital, and referrals to hospital determined by independent audit of the general practices. The former may be regarded as a surrogate for the latter, which is regarded as the true endpoint. Data are only available for the true end point on a sub set of the practices, but there are surrogate data for almost all of the audited practices and for most of the remaining practices. METHODS The aim of this paper was to estimate the treatment effect using data from every practice in the study. Where the true endpoint was not available, it was estimated by three approaches, a regression method, multiple imputation and a full likelihood model. RESULTS Including the surrogate data in the analysis yielded an estimate of the treatment effect which was more precise than an estimate gained from using the true end point data alone. CONCLUSIONS The full likelihood method provides a new imputation tool at the disposal of trials with surrogate data.
منابع مشابه
A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint.
A surrogate endpoint is an endpoint that is obtained sooner, at lower cost, or less invasively than the true endpoint for a health outcome and is used to make conclusions about the effect of intervention on the true endpoint. In this approach, each previous trial with surrogate and true endpoints contributes an estimated predicted effect of intervention on true endpoint in the trial of interest...
متن کاملبینش پشت استفاده از بیومارکرهای IFN-G، IL-2، IL-4 و IL-10بهعنوان نقاط پایانی جانشین برای ابتلا به بیماری-های پوستی ناشی از مواجهه با گاز خردل
Background and Objective: Here,it is tried to assess an insight behind using IFN-G,IL-2,IL-4,and IL-10 biomarkers as potential surrogate endpoints for skin diseases caused by exposure to mustard gas. Potentially,a biomarker is a valid surrogate if assessment of the treatment effect based on surrogate endpoint leads to the same result based on true clinical endpoint. Materials and Methods: In S...
متن کاملA perfect correlate does not a surrogate make
BACKGROUND There is common belief among some medical researchers that if a potential surrogate endpoint is highly correlated with a true endpoint, then a positive (or negative) difference in potential surrogate endpoints between randomization groups would imply a positive (or negative) difference in unobserved true endpoints between randomization groups. We investigate this belief when the pote...
متن کاملبررسی اعتبار جانشینی سایتوکاینهای Th1 و Th2 در بیماران مبتلا به عارضه پوستی ناشی از اثرهای درازمدت گاز خردل
Background & Objective : We study Surrogacy validation of Th1 and Th2, when the true endpoint is Long-term Skin Effects of Exposure to Mustard Gas based on “Martyrs and Veterans Affair” assignment. Materials & Methods : This study is a part of Sardasht-Iran cohort study. 327 chemical victims of sulfur mustard from Sardasht and 128 controlled, totally 500 persons, are studied. Results : Tr...
متن کاملPackage ‘ Surrogate ’
August 18, 2017 Type Package Title Evaluation of Surrogate Endpoints in Clinical Trials Version 0.4 Date 2017-08-18 Author Wim Van der Elst, Paul Meyvisch, Ariel Alonso, Hannah M. Ensor, Christopher J. Weir & Geert Molenberghs Maintainer Wim Van der Elst Description In a clinical trial, it frequently occurs that the most credible outcome to evaluate the effectiveness ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- BMC Medical Research Methodology
دوره 3 شماره
صفحات -
تاریخ انتشار 2003